For the year ending 2025-12-31, ECL had -$610,600K decrease in cash & cash equivalents over the period. $1,904,300K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income including noncontrolling interest | 2,093,300 | 2,131,900 | 1,393,000 | 1,108,900 |
| Depreciation | 672,600 | 634,900 | 616,700 | 618,500 |
| Amortization | 303,800 | 300,500 | 306,900 | 320,200 |
| Deferred income taxes | -33,400 | -190,500 | -55,700 | -142,600 |
| Share-based compensation expense | 136,600 | 134,800 | 95,100 | 87,800 |
| Pension and postretirement plan contributions | 77,800 | 54,400 | 109,300 | 64,300 |
| Pension and postretirement plan expense (income), net | 15,000 | 14,300 | 3,100 | 45,500 |
| Restructuring charges, net of cash paid | 18,800 | 23,700 | -32,600 | 66,200 |
| Sale of global surgical solutions business | -1,100 | 381,700 | - | - |
| Other, net | -28,800 | -24,300 | -31,900 | -24,900 |
| Accounts receivable | 185,900 | 146,700 | 84,300 | 319,600 |
| Inventories | -36,400 | 115,600 | -320,300 | 402,900 |
| Other assets | -83,600 | 24,300 | -72,200 | 278,200 |
| Accounts payable | 67,700 | 300,000 | -232,300 | 394,700 |
| Other liabilities | -208,000 | 162,700 | 86,800 | 329,300 |
| Cash provided by operating activities - continuing operations | - | - | - | 1,788,400 |
| Cash provided by operating activities | 2,952,600 | 2,813,900 | 2,411,800 | 1,788,400 |
| Capital expenditures | 1,048,300 | 994,500 | - | 712,800 |
| Property and other assets sold | 52,300 | 11,300 | - | 2,200 |
| Acquisitions and investments in affiliates, net of cash acquired | 1,621,300 | 312,900 | - | 7,200 |
| Divestiture of businesses, net of cash divested | -14,900 | 889,700 | - | - |
| Other, net | 75,000 | 27,400 | - | -1,000 |
| Cash used for investing activities - continuing operations | - | - | - | -716,800 |
| Cash used for investing activities | -2,707,200 | -433,800 | -990,500 | -716,800 |
| Net issuances (repayments) of commercial paper and notes payable | 98,200 | 1,900 | - | -404,300 |
| Long-term debt borrowings | 1,045,600 | - | - | 494,000 |
| Long-term debt repayments | 674,200 | 630,400 | - | - |
| Reacquired shares | 783,800 | 986,500 | - | 518,200 |
| Dividends paid | 753,600 | 664,300 | - | 602,800 |
| Exercise of employee stock options | 228,200 | 259,400 | - | 29,100 |
| Hedge settlements | - | 600 | - | -172,000 |
| Other, net | -13,700 | -3,600 | - | -7,100 |
| Cash (used for) provided by financing activities - continuing operations | - | - | - | -837,300 |
| Cash used for financing activities | -853,300 | -2,024,100 | -1,054,700 | -837,300 |
| Effect of exchange rate changes on cash and cash equivalents | -2,700 | -18,700 | -45,700 | 4,400 |
| Increase (decrease) in cash and cash equivalents | - | - | 320,900 | 238,700 |
| (decrease) increase in cash and cash equivalents | -610,600 | 337,300 | - | - |
| Cash and cash equivalents, beginning of period | 1,256,800 | 919,500 | 598,600 | - |
| Cash and cash equivalents, end of period | 646,200 | 1,256,800 | 919,500 | - |
ECOLAB INC. (ECL)
ECOLAB INC. (ECL)